AccessPak for HIV PEP Expanded with Kaletra and Oritavancin Diphosphate
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Oritavancin Diphosphate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: oritavancin
Brand name: Orbactiv
Synonyms: Oritavancin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Oritavancin Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Orkambi
- AccessPak for HIV PEP Expanded with Kaletra-Orkambi (Lumacaftor and Ivacaftor Granules)
- AccessPak for HIV PEP Expanded with Kaletra-Orkambi (Lumacaftor and Ivacaftor Tablets)
- AccessPak for HIV PEP Expanded with Kaletra-Orlistat
- AccessPak for HIV PEP Expanded with Kaletra-Ornex
- Oritavancin Diphosphate-AccessPak for HIV PEP Expanded with Viracept
- Oritavancin Diphosphate-Accolate
- Oritavancin Diphosphate-Accretropin
- Oritavancin Diphosphate-Accucaine
- Oritavancin Diphosphate-AccuHist Drops
- Oritavancin Diphosphate-AccuHist PDX Drops